Skip to content

AI for Biostatisticians

Individual Contributor10 daily tasks

Also known as: Statistical Scientist, Senior Biostatistician

This role isn't yet mapped to specific AI applications in our industry library. The day-to-day breakdown below is the authored view of the work.

A Day in the Life

How AI changes daily work for Biostatisticians

You design the statistical backbone of clinical trials — sample sizes, randomization schemes, analysis plans, and the regulatory-grade analyses that determine if a drug works. The FDA reads your tables before anything else.

Sorted by impact — tasks changing the most are at the top.

Perform sample size calculation
Automates✓ Now

What you do today

Estimate required sample size based on effect size, variability, power, alpha — account for dropout, interim analyses, adaptive design elements

AI that applies

AI simulates thousands of trial scenarios to optimize sample size under various assumptions about effect size, dropout rates, and enrollment patterns

How it works

For perform sample size calculation, the system draws on the relevant operational data and applies the appropriate analytical models. The simulation engine runs thousands of scenarios by varying each uncertain input across its probability range, building a distribution of outcomes that quantifies the risk. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

Simulation-based sample sizing runs thousands of scenarios automatically instead of manual sensitivity tables; identifies the most efficient design

What Stays

You choose the assumptions, interpret regulatory acceptability of adaptive designs, and defend the sample size rationale to FDA

Review CDISC dataset specifications
Automates✓ Now

What you do today

Ensure SDTM and ADaM datasets comply with CDISC standards, review dataset specs with data management, validate derivation logic

AI that applies

AI validates CDISC compliance automatically, flags deviations from SDTM/ADaM standards, and suggests conformant variable mappings

How it works

The system ingests SDTM/ADaM standards as its primary data source. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

CDISC validation is automated and comprehensive; AI catches compliance issues that manual review might miss across hundreds of variables

What Stays

You make decisions about custom domains, non-standard variables, and how to handle edge cases that don't fit standard CDISC models

Validate statistical programming output
Automates✓ Now

What you do today

Independently program key analyses as QC check against primary programmer, reconcile discrepancies, ensure double-programming compliance

AI that applies

AI assists with independent QC programming, automatically compares outputs, and identifies discrepancies at the cell level in TFLs

How it works

For validate statistical programming output, the system identifies discrepancies at the cell level in tfls. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

QC programming is faster; AI automatically highlights discrepancies between primary and QC outputs instead of manual comparison

What Stays

You investigate discrepancies, determine root cause, and ensure the final validated output is correct — accuracy is non-negotiable

Design randomization scheme
Enhances✓ Now

What you do today

Define stratification factors, block sizes, randomization ratios — balance scientific rigor with operational feasibility across trial sites

AI that applies

AI optimizes stratification and dynamic randomization (minimization) parameters to maximize balance across prognostic factors

How it works

For design randomization scheme, the system draws on the relevant operational data and applies the appropriate analytical models. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

AI simulates enrollment scenarios to identify which stratification factors matter most and optimal block sizes for your site structure

What Stays

You decide the randomization strategy based on regulatory precedent, site capabilities, and clinical considerations

Run interim analysis for Data Safety Monitoring Board
Enhances✓ Now

What you do today

Execute pre-planned interim analysis, prepare DSMB report with futility/efficacy boundaries, present results under strict unblinding protocols

AI that applies

AI automates DSMB report generation from clinical database, performs group sequential calculations, and generates standardized safety tables

How it works

The system ingests clinical database as its primary data source. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The output — standardized safety tables — surfaces in the existing workflow where the practitioner can review and act on it.

What Changes

Report generation is faster and more standardized; AI ensures all pre-specified analyses are included without manual checklist review

What Stays

You ensure statistical integrity of the interim analysis, maintain the firewall, and present results with appropriate caveats to the DSMB

Perform primary efficacy analysis for CSR
Enhances✓ Now

What you do today

Execute the pre-specified primary analysis from the SAP, run sensitivity analyses, produce TFLs (tables, figures, listings) for the clinical study report

AI that applies

AI-assisted programming generates validated TFLs faster, automatically QC's output against SAP specifications, and flags discrepancies

How it works

For perform primary efficacy analysis for csr, the system draws on the relevant operational data and applies the appropriate analytical models. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The output — validated TFLs faster — surfaces in the existing workflow where the practitioner can review and act on it.

What Changes

TFL programming is faster with AI code generation; AI validates output against SAP and catches programming errors before peer review

What Stays

You interpret the results, write the statistical interpretation, and determine if the trial met its primary objective

Write Statistical Analysis Plan for Phase III trial
Enhances◐ 1–3 yrs

What you do today

Define primary endpoint analysis, handling of missing data, multiplicity adjustments, sensitivity analyses, subgroup analyses — document in ICH E9-compliant SAP

AI that applies

AI drafts SAP sections from protocol parameters, suggests appropriate statistical methods based on endpoint type, and ensures ICH E9(R1) compliance

How it works

The system ingests protocol parameters as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The output is a recommended plan or schedule that accounts for the identified constraints and optimization criteria.

What Changes

First draft SAP generated in hours; AI suggests best-practice analysis approaches for your specific endpoint and design

What Stays

You make the statistical design decisions — primary analysis method, estimand framework, missing data approach — these require deep statistical judgment

Handle missing data analysis
Enhances◐ 1–3 yrs

What you do today

Implement missing data methods (MMRM, multiple imputation, pattern-mixture models, tipping point analyses) per ICH E9(R1) estimand framework

AI that applies

AI automates sensitivity analyses across multiple missing data assumptions, generates tipping point analysis results, and visualizes impact on conclusions

How it works

The system ingests across multiple missing data assumptions as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The output — tipping point analysis results — surfaces in the existing workflow where the practitioner can review and act on it.

What Changes

Running 20 sensitivity analyses instead of 5 becomes feasible; AI comprehensively tests robustness of conclusions to missing data assumptions

What Stays

You define the estimand, choose the primary missing data approach, and interpret whether the results are robust — regulatory judgment is key

Consult with clinical team on trial design
Enhances◐ 1–3 yrs

What you do today

Advise on endpoint selection, design trade-offs (parallel vs crossover, superiority vs non-inferiority), power implications of design choices

AI that applies

AI simulates trial outcomes under different design options, quantifying trade-offs in power, cost, and timeline for each alternative

How it works

The system ingests clinical data — patient records, lab results, vitals, and care history from the EHR. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

You bring quantified trade-offs to design discussions instead of conceptual arguments; AI shows 'if we switch to crossover, power increases 12% but dropout risk rises'

What Stays

You provide the statistical judgment that balances scientific rigor with operational reality and regulatory expectations

Prepare for FDA statistical review meeting
Enhances◐ 1–3 yrs

What you do today

Anticipate FDA statistical reviewer questions, prepare backup analyses, build defense for your analytical approach

AI that applies

AI analyzes FDA review histories for similar drugs and endpoints, identifies common statistical objections, and suggests pre-emptive analyses

How it works

The system ingests FDA review histories for similar drugs and endpoints as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.

What Changes

FDA precedent research is comprehensive; AI identifies how FDA statistical reviewers responded to similar designs and methods

What Stays

You prepare the statistical defense, anticipate follow-up questions, and represent the statistical case to regulators

6 tasks AI-ready now 4 tasks within 1–3 yrs

Build your AI roadmap

Get a prioritized list of AI applications for your industry — ranked by impact and readiness.